Samira Mubareka
Cracking the SARS-CoV-2 Code
Text from poster
During the COVID-19 outbreak, Mubareka successfully led a collaborative effort to isolate the SARS-CoV-2 virus in a containment level 3 facility and sequence the genetic code, allowing medical researchers to develop new therapies and vaccines to fight the pandemic by broadly sharing material and data.
Additional Information
Her expertise in virology and pathogen transmission led to her to serve in several roles, including as a member of the Chief Science Advisor of Canada’s COVID-19 Expert Panel, the Implementation Committee of the Canadian COVID-19 Genomics Network Viral Sequencing Project (Genome Canada) and the Ontario COVID-19 Science Advisory Table. She is also the Chair of the Royal Society of Canada’s One Health Working Group. She has furthered our understanding of how viruses spread through the air in collaboration with fluid dynamics engineers and clinical epidemiologists, and between different hosts through her work with partners in animal health. In 2021, she was a key contributor to the discovery of SARS-CoV-2 in Canadian wildlife.
She obtained an undergraduate degree from the University of New Brunswick, then obtained a medical degree from Dalhousie. She then specialized in internal medicine at McGill and Infectious diseases at the University of Manitoba. Since completing her fellowship at Mount Sinai School of Medicine in New York, she has focused her research on viral transmission.
